Status:
ACTIVE_NOT_RECRUITING
Onabotulinum Toxin A in Direct Brow Lift
Lead Sponsor:
Nova Scotia Health Authority
Collaborating Sponsors:
Dalhousie University
Conditions:
Direct Brow Lift
Scarring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The brow lift is a surgical procedure that has been practiced for several decades. A typical indication is brow ptosis, which can be secondary to involutional changes or facial nerve palsies. Several ...
Eligibility Criteria
Inclusion
- The patient population to be studied will include patients undergoing bilateral direct brow lifts at the Victoria General Hospital in Halifax, Nova Scotia.
- Patients must meet all of the following inclusion criteria, and have none of the exclusion criteria listed below.
- Inclusion criteria:
- Participants must be over 18 years of age
- Participants must be able to attend outpatient appointments at the Victoria General Hospital
- Participants must be able to give informed consent
- Exclusion criteria:
- Known allergy to botulinum toxin
- Previous scarring in same region of surgical procedure
- Previous botulinum toxin injection within 6 months of surgical date for direct brow lift
- Currently pregnant or breast feeding
- History of keloid or hypertrophic scarring
- History of myasthenia gravis/ neuromotor disorder
Exclusion
Key Trial Info
Start Date :
November 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04383912
Start Date
November 18 2020
End Date
July 1 2024
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Care Centre, Victoria General Hospital
Halifax, Nova Scotia, Canada, B3H 2Y9